QC Kinetix: a leader in regenerative medicine, is revolutionizing the medical field.

QC Kinetix, a pioneering force in regenerative medicine, has rapidly established itself since its founding in 2017. The company provides cutting-edge, non-surgical treatments for joint pain and discomfort, serving patients across more than 100 cities nationwide. Their therapies aim to harness the body’s natural regenerative abilities to enhance musculoskeletal health without resorting to surgery.

In May 2024, Entrepreneur magazine recognized QC Kinetix as one of the top 10 New and Emerging Franchises of 2024, securing the 9th position. This honor highlights the company’s remarkable growth, with a staggering 2,111% increase in units over the past three years, underscoring its robust financial performance and expanding influence.

The CEO of QC Kinetix stated, “We’re honored to rank among some of the fastest-growing franchise brands,” “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”

QC Kinetix Gains Industry Backing from Leading Experts

QC Kinetix is dedicated to providing an exceptional alternative for pain management, driven by a deep commitment to enhancing lives. The company offers effective treatments for chronic pain that avoid the use of medications, surgeries, or steroids. Their unique approach employs proprietary biologics treatment protocols, showcasing their dedication through successful outcomes for thousands of patients.

The recent appointment of Dr. Mitchell Sheinkop as the national medical director further underscores the company’s commitment to excellence. Dr. Sheinkop, a renowned orthopedic surgeon with over 37 years of experience in joint replacement, joins QC Kinetix with a strong belief in the potential of regenerative medicine and a focus on patient care.

In his new role, Dr. Sheinkop will oversee the medical management team, refine treatment protocols, and lead research efforts. He aims to enhance patient outcomes by incorporating physical therapy and weight management into treatment plans, thereby amplifying the brand’s impact.

With Dr. Sheinkop’s leadership, QC Kinetix is poised for a transformative phase, leveraging his extensive clinical background and dedication to advancement to drive innovation and success.

Pro Football Hall of Famer Emmitt Smith, who serves as the national spokesperson for QC Kinetix, commented, “I’ve got to keep taking care of these joints,” Smith said, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”

Introduction of QC Kinetix

QC Kinetix originated from a collaborative vision shared by a diverse team: a medical doctor, a physician assistant, a nurse practitioner, and a business professional. Their shared goal and roots in Charlotte, North Carolina—affectionately known as “the Queen City” (QC)—inspired the company’s name.

The term “Kinetix” symbolizes dynamic motion and energy, reflecting QC Kinetix’s mission to restore mobility through the body’s natural regenerative capabilities.

Recognizing a significant opportunity to transform the management of musculoskeletal pain, the founders established a concierge medical model that emphasizes regenerative medicine. QC Kinetix stands out in the industry with its novel method to greatly enhance patients’ quality of life.

Patients often seek out QC Kinetix when pain impedes their ability to enjoy activities like golfing, climbing stairs, or playing with grandchildren. The clinic provides cutting-edge treatments that avoid the pitfalls of conventional medications and invasive surgeries.

“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” said a company spokesperson. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”

QC Kinetix Adopts a Patient-Centric Approach to Treatment

As a trailblazer in regenerative medicine, QC Kinetix is dedicated to helping individuals maintain active lives by addressing musculoskeletal and joint pain with advanced regenerative treatments. The company harnesses the body’s natural healing processes through sophisticated biological therapies, providing effective alternatives to invasive surgeries and addictive medications.

The clinics prioritize enhancing the body’s inherent repair mechanisms, leading to notable improvements in functionality and overall quality of life. Patients frequently come to QC Kinetix seeking relief from knee, shoulder, or hip pain, benefiting from treatments that utilize the body’s regenerative capabilities.

Since its inception, QC Kinetix has achieved remarkable milestones, including surpassing $100 million in system-wide sales in 2023. By April 2024, the company had treated its 40,000th patient, following its national expansion in 2021.

“It is our goal to change medicine,” stated the CEO of QC Kinetix. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”

QC Kinetix Set for Major Global Expansion

Building on its strong foothold in the U.S., QC Kinetix is now preparing for significant international growth, with plans to enter the markets of the United Kingdom, Australia, and New Zealand. This global expansion aims to reinforce QC Kinetix’s position as a leading force in regenerative medicine, to operate 250 locations across the U.S. by the end of 2024.

Reflecting on the company’s swift expansion, the CEO remarked, “The only surprise is that our growth hasn’t accelerated even faster, given the increasing demand for alternatives to traditional pain treatments. This rapid expansion highlights the robust market interest in non-surgical pain relief and the strong appeal to franchise investors in the healthcare industry.”

“I love this brand and our future,” the CEO of QC Kinetix said. “It’s about impacting people’s lives and being a game-changer in the medical field.”